Chios mastic gum extracts as a potent antitumor agent that inhibits growth and induces apoptosis of oral cancer cells

Asian Pac J Cancer Prev. 2011;12(7):1877-80.

Abstract

Purpose: The purpose was to investigate Chios mastic gum (CMG) extract as an potential anti-tumor agent for oral squamous cell carcinoma in vitro.

Methods: We designed a study to examine the effects of CMG extracts on growth of oral squamous cell carcinoma cell line, YD-10B and to determine whether the extracts could induce apoptosis through the activation of caspase-3, using the common chemotherapeutic agent Paclitaxel (Taxol, Bristol-Myers Squibb) as a control.

Results: MTT assay suggested that both CMG and Taxol inhibited the proliferation of YD-10B cells in a time and dose dependent manner. Moreover, 10 μg/mL of CMG and 50 μg/mL of Taxol caused fragmentation of the genomic DNA at 24 hour. Finally, 10 μg/mL of CMG and 50 μg/mL of Taxol caused cleavage of procaspase-3 in western blot analysis.

Conclusions: These results suggest CMG's potential as an anti-tumor agent.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Apoptosis / drug effects*
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / pathology
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • DNA / drug effects
  • DNA / metabolism
  • Drug Screening Assays, Antitumor
  • Humans
  • Mastic Resin
  • Mouth Neoplasms / drug therapy*
  • Mouth Neoplasms / pathology
  • Paclitaxel / pharmacology
  • Paclitaxel / therapeutic use
  • Pistacia / chemistry
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Resins, Plant / pharmacology*
  • Resins, Plant / therapeutic use

Substances

  • Antineoplastic Agents, Phytogenic
  • Mastic Resin
  • Plant Extracts
  • Resins, Plant
  • DNA
  • CASP3 protein, human
  • Caspase 3
  • Paclitaxel